Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Possible mechanism for zonisamide-induced hyperammonemia in a child with citrullinemia type 1.

Shaikh AY, Muranjan MN, Gogtay NJ, Lahiri KR.

Indian J Med Sci. 2009 May;63(5):203-6. doi: 10.4103/0019-5359.53168. No abstract available.

PMID:
19584493
2.

Renal tubular acidosis associated with zonisamide therapy in a dog.

Cook AK, Allen AK, Espinosa D, Barr J.

J Vet Intern Med. 2011 Nov-Dec;25(6):1454-7. doi: 10.1111/j.1939-1676.2011.00801.x. Epub 2011 Sep 21. No abstract available.

3.

Urine stone formation during treatment with zonisamide.

Miyamoto A, Sugai R, Okamoto T, Shirai M, Oki J.

Brain Dev. 2000 Oct;22(7):460. No abstract available.

PMID:
11221704
4.

Apparent acute idiosyncratic hepatic necrosis associated with zonisamide administration in a dog.

Miller ML, Center SA, Randolph JF, Lepherd ML, Cautela MA, Dewey CW.

J Vet Intern Med. 2011 Sep-Oct;25(5):1156-60. doi: 10.1111/j.1939-1676.2011.00783.x. Epub 2011 Aug 30. No abstract available.

5.

Valproate-induced hyperammonemia as a cause of altered mental status.

Feil D, Chuang K, Sultzer DL.

Am J Geriatr Psychiatry. 2002 Jul-Aug;10(4):476-8.

PMID:
12095907
6.

Zonisamide-induced restless legs syndrome.

Chen JT, Garcia PA, Alldredge BK.

Neurology. 2003 Jan 14;60(1):147. No abstract available.

PMID:
12525743
7.

Zonisamide-induced psychosis in a patient with bipolar disorder and narcolepsy.

Platt JE, Opler LA, Platt EM.

Am J Ther. 2014 May-Jun;21(3):e88-9. doi: 10.1097/MJT.0b013e31824d617f.

PMID:
22713527
8.

Psychosis induced by zonisamide: a case report and review of the literature.

Abdoh M, Mersfelder TL, Melgar TA.

Am J Ther. 2014 Jan-Feb;21(1):e15-6. doi: 10.1097/MJT.0b013e318230ae7b.

PMID:
22020087
9.

[Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].

Jiménez-Parrilla F, Pérez-Sánchez A, Núñez-Solís JM, Madruga-Garrido M, Losada-Martínez A.

Rev Neurol. 2009 Jun 1-15;48(11):613-4. Spanish. No abstract available.

10.

Zonisamide for absence seizures.

Wilfong A, Schultz R.

Epilepsy Res. 2005 Mar-Apr;64(1-2):31-4. Epub 2005 Apr 19. Review.

PMID:
15847848
11.

Zonisamide-induced mania in an essential tremor patient.

Sullivan KL, Ward CL, Zesiewicz TA.

J Clin Psychopharmacol. 2006 Aug;26(4):439-40. No abstract available.

PMID:
16855471
12.

Zonisamide for seizures in Parkinson's disease with dementia.

Tombini M, Pellegrino G, Di Pino G, Assenza G.

Seizure. 2013 May;22(4):324-5. doi: 10.1016/j.seizure.2013.01.011. Epub 2013 Feb 8. No abstract available.

13.

Zonisamide approved for partial seizures.

[No authors listed]

Am J Health Syst Pharm. 2000 May 1;57(9):834, 837. No abstract available.

PMID:
10840516
14.

Zonisamide.

Seino M, Miyazaki H, Ito T.

Epilepsy Res Suppl. 1991;3:169-74. Review. No abstract available.

PMID:
1777076
15.

Zonisamide and associated oligohidrosis and hyperthermia.

Low PA, James S, Peschel T, Leong R, Rothstein A.

Epilepsy Res. 2004 Nov;62(1):27-34. Review.

PMID:
15519129
16.

Hyperammonemia with citrullinemia.

Karnik D, Thomas N, Jacob J, Oommen A.

Indian Pediatr. 2004 Aug;41(8):842-4.

17.

A cautionary note when using zonisamide in youths: a case report of association with toxic epidermal necrolysis.

Majeres KD, Suppes T.

J Clin Psychiatry. 2004 Dec;65(12):1720. No abstract available.

PMID:
15641880
18.

Neuroleptic malignant syndrome-like state in an epileptic patient with organic brain comorbidity treated with zonisamide and carbamazepine.

Azuma H, Negi A, Hattori M, Masayasu T, Akechi T, Furukawa TA.

Epilepsia. 2007 Oct;48(10):1999-2001. No abstract available.

19.

Zonisamide-induced suicidal ideation.

Mago R, Huege S, Ahuja N, Kunkel EJ.

Psychosomatics. 2006 Jan-Feb;47(1):68-9. No abstract available.

PMID:
16384810
20.

Zonisamide as treatment for seizures.

Davenport RD, Patel NC.

Nurse Pract. 2007 Apr;32(4):15-7. No abstract available.

PMID:
17414822

Supplemental Content

Support Center